[ad_1]
“We will definitely look for flexibility so that especially those municipalities that have so far been successful in vaccinating all the vaccines that they only receive, can move faster up the priority list. So far, we don’t have enough vaccines to vaccinate everyone who wants to come. to the Cathedral, Kudirka or Independence Square, ”said I. Šimonytė.
However, the Prime Minister pointed out that already in April, with more and more vaccines received, it might be possible to talk about administering doses of vaccines that were not used that day to people who are not necessarily a priority, as is the case in Israel.
“I would not rule out that in Lithuania you can see a phenomenon similar to that in Israel, when at the end of the day the vaccine that was not used in the priority queue was vaccinated. But now we have many people in the risk group who have not yet been “unlocked”, explained I. Šimonytė.
It is true that Health Minister Arūnas Dulkys told LRT radio this Thursday morning that after the resumption of the currently suspended vaccination with the AstraZeneca COVID-19 vaccine, it is considering allowing vaccination to anyone who wishes without priority .
“At the moment, since our vaccination strategy and all logistics were based only on vaccinating priority groups, we will probably now reconsider this vaccine as well, maybe we will change those solutions and maybe allow those who want to vaccinate. But no final decisions have been made here yet, “said A. Dulkys.
Waiting for a positive decision from the EEA
According to the Prime Minister, so far only AstraZeneca vaccine stocks are accumulating in the stocks of vaccination centers in Lithuania.
“There are many legends and stories about that accumulation. There is a particular type of vaccine that is now available in vaccination establishments, other vaccines are really being vaccinated with success, even though they don’t accumulate much because they have a special temperature regime and must be used if they are produced, “he said. saying.
The prime minister added that the EEA’s decision on further vaccination with AstraZeneca is expected on Thursday. I. Šimonytė hopes that this decision will be positive.
“I am very hopeful that today the EVA will be such that the doubts that have arisen here about certain accidents or health problems will eventually be disengaged from the vaccination process, and that the benefits of vaccination outweigh the harms once again.” The minister spoke.
On Tuesday night, Health Minister Arūnas Dulkys announced the temporary suspension of vaccination with the AstraZeneca vaccine until the European Medicines Agency presents final conclusions on the connection of thromboembolic cases with the vaccine.
On the same day, the European Medicines Agency said there was “no indication” that a vaccine developed by AstraZeneca and the University of Oxford could cause blood clots in some people who had been vaccinated.
